It has been reported before that the circadian clock pathway is involved in cancer in addition to its key role in the regulation of circadian rhythm [28, 29], while the circadian clock pathway member BMAL1 can act as either a tumor suppressor or oncogene in different malignancies [29–31]. Here, BMAL1 is linked to neoplasm.